he should be a stunned mullet. It was his words to follow the science. Not sure what that meant for depression. I can understand the science for Alzheimer’s effect but not depression. So no improvement in cognition goes against Xanamem IMO. Someone needs to show why the placebo result was wrong. At present all management is saying is that it was totally unexpected.
- Forums
- ASX - By Stock
- Ann: ACW XanaCIDD phase 2a trial topline results
he should be a stunned mullet. It was his words to follow the...
-
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACW (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.9¢ |
Change
-0.002(6.45%) |
Mkt cap ! $78.63M |
Open | High | Low | Value | Volume |
3.0¢ | 3.1¢ | 2.9¢ | $181.2K | 6.113M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 3270301 | 2.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 1238266 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 3340029 | 0.029 |
10 | 1363680 | 0.028 |
12 | 914259 | 0.027 |
13 | 3261088 | 0.026 |
19 | 3687643 | 0.025 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 1238266 | 8 |
0.031 | 2477817 | 9 |
0.032 | 1627719 | 9 |
0.033 | 1978769 | 10 |
0.034 | 1535552 | 8 |
Last trade - 10.53am 13/08/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online